Cell producing replicative retroviral vector

Title:

Cell producing replicative retroviral vector

Document Type and Number:

Japanese Patent JP6335869

Kind Code:

B2

Abstract:

The disclosure provides for replication competent retroviruses produced from cell lines adapted to being grown and continuously passaged in serum free media and in suspension, methods of production thereof, and uses thereof in gene therapy.

More Like This:

JPH08337539	RECOMBINANT LIVE VACCINE FOR BIRD BASED ON BIRD HERPES VIRUSAND ESPECIALLY VACCINE FOR GANBORO SICKNESS
JP2024515369	Stable production system for adeno-associated virus production
WO/1998/021317	VIRAL VARIANTS AND METHODS FOR DETECTING SAME

Inventors:

Jolly, Douglas, Jay.
Carlos, Ibanez

Application Number:

JP2015251391A

Publication Date:

May 30, 2018

Filing Date:

December 24, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Tokagen Incorporated

International Classes:

C12N7/01; A61K35/76; A61P35/00; A61P43/00; C12N5/09; C12N5/10; C12N15/09; C12N15/113

Domestic Patent References:

JP6500923A

Foreign References:

WO2003060101A1

Other References:

Cancer Gene Therapy,2005,Vol.12,pp.464-474
Cancer Research,1994,Vol.54,pp.1503-1506

Attorney, Agent or Firm:

Yusuke Hiraki
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Kosemura Akiko

Previous Patent: A method and a device which manufacture sandwiched type parts

Next Patent: JIG FOR INCORPORATING ASSEMBLY PARTS